[1] |
ASRANI S K, DEVARBHAVI H, EATON J, et al. Burden of liver diseases in the world[J]. J Hepatol, 2019, 70(1):151-171.
DOI
URL
|
[2] |
慢性乙型肝炎临床治愈(功能性治愈)专家共识[J]. 中华临床感染病杂志, 2019, 12(4):241-252.
|
[3] |
孙乐科, 吴俭. 维生素D对脓毒症小鼠炎症的抑制作用[J]. 江西医药, 2017, 52(1):45-47.
|
[4] |
张利娟, 童巧霞. 慢性乙型肝炎肝纤维化患者血清25羟维生素D3水平临床研究[J]. 中华疾病控制杂志, 2018, 22(10):1016-1019.
|
[5] |
皮小芳, 周红宇, 阳学风. 维生素D与肝纤维化关系研究进展[J]. 临床消化病杂志, 2018, 30(5):329-332.
|
[6] |
耿坤静, 刘洋, 陈思思, 等. CHB患者血清25(OH)D_3水平与肝脏炎症活动度及纤维化程度的相关性分析[J]. 标记免疫分析与临床, 2021, 28(8):1371-1374.
|
[7] |
MOHAMED A A, ABDO S, SAID E, et al. Serum vitamin D levels in chronic hepatitis B patients before and during treatment[J]. Infect Disord Drug Targets, 2020, 20(6):840-847.
DOI
URL
|
[8] |
王贵强, 王福生, 庄辉, 等. 慢性乙型肝炎防治指南(2019年版)[J]. 中国病毒病杂志, 2020, 10(1):1-25.
|
[9] |
陈成伟, 陈从新, 陈士俊, 等. 核苷和核苷酸类药物治疗慢性乙型肝炎的耐药及其管理[J]. 传染病信息, 2013, 26(1):1-9.
|
[10] |
柯昌征, 刘平, 陈丽娥, 等. 乙型肝炎患者维生素D缺乏的相关研究[J]. 中西医结合肝病杂志, 2015, 25(2):83-85.
|
[11] |
HOAN N X, TONG H V, SONG L H, et al. Vitamin D deficiency and hepatitis viruses-associated liver diseases:a literature review[J]. World J Gastroenterol, 2018, 24(4):445-460.
DOI
URL
|
[12] |
陈丽萍, 周建. 维生素D3联合复方甘草酸苷恩替卡韦治疗慢性乙型肝炎患者的临床研究[J]. 山西医药杂志, 2018, 47(22):2654-2657.
|
[13] |
徐静, 李传杰, 王亮亮, 等. 维生素D3联合恩替卡韦对乙型肝炎肝硬化代偿期患者外周血T淋巴细胞水平及肝纤维化指标的影响[J]. 肝脏, 2019, 24(7):795-798.
|
[14] |
AKCAM F Z, TIGLI A, KAYA O, et al. Cytokine levels and histopathology in chronic hepatitis B and chronic hepatitis C[J]. J Interferon Cytokine Res, 2012, 32(12):570-574.
DOI
URL
|
[15] |
FARNIK H, BOJUNGA J, BERGER A, et al. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients[J]. Hepatology, 2013, 58(4):1270-1276.
DOI
URL
|
[16] |
MORA J R, IWATA M, VON ANDRIAN U H. Vitamin effects on the immune system:vitamins A and D take centre stage[J]. Nat Rev Immunol, 2008, 8(9):685-698.
DOI
URL
|